Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.55 Million GBP | 7.62% |
| 2022 | -9.26 Million GBP | -50.11% |
| 2021 | -6.16 Million GBP | -124.13% |
| 2020 | -2.75 Million GBP | -25.71% |
| 2019 | -2.18 Million GBP | 10.09% |
| 2018 | -2.43 Million GBP | -117.58% |
| 2017 | -1.11 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.32 Million GBP | 0.0% |
| 2024 Q1 | -2.32 Million GBP | -15.25% |
| 2023 Q4 | -2.01 Million GBP | 0.0% |
| 2023 FY | -8.55 Million GBP | 7.62% |
| 2023 Q2 | -4.52 Million GBP | -100.0% |
| 2023 Q3 | -2.01 Million GBP | 55.54% |
| 2023 Q1 | -2.26 Million GBP | 53.73% |
| 2022 Q2 | -4.36 Million GBP | -100.0% |
| 2022 Q1 | -2.18 Million GBP | 28.72% |
| 2022 Q4 | -4.89 Million GBP | -100.0% |
| 2022 FY | -9.26 Million GBP | -50.11% |
| 2022 Q3 | -2.44 Million GBP | 43.98% |
| 2021 Q3 | -1.53 Million GBP | 50.69% |
| 2021 Q2 | -3.1 Million GBP | -99.97% |
| 2021 FY | -6.16 Million GBP | -124.13% |
| 2021 Q1 | -1.55 Million GBP | 8.92% |
| 2021 Q4 | -3.06 Million GBP | -100.03% |
| 2020 Q3 | -852.58 Thousand GBP | 18.56% |
| 2020 Q2 | -1.04 Million GBP | -100.0% |
| 2020 Q1 | -523.41 Thousand GBP | 0.0% |
| 2020 FY | -2.75 Million GBP | -25.71% |
| 2020 Q4 | -1.7 Million GBP | -100.0% |
| 2019 FY | -2.18 Million GBP | 10.09% |
| 2018 FY | -2.43 Million GBP | -117.58% |
| 2017 FY | -1.11 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|